Recently, the “adiponectin paradox” emerged in the literature as it was discovered that some patients with obesity exhibit high adiponectin concentrations without the beneficial effects of this adipokine [53,64]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.